Which of these is not a reason for using a placebo?A.To have a control group to test the drug's effectiveness against a diseaseB.To determine which of two pills is a better choice for treating a diseaseC.So that the effect of a patient's mind is taken into account in the drug testingD.So that all patients will believe their disease is being treated

In an experiment to see if aspirin reduces the chance of having a heart attack, which of the following would be a placebo? The sampling method The randomization procedure A procedure for deciding who gets the aspirin treatment The place where the subjects go when they have a heart attack A dummy pill that looks like aspirin but has no active ingredients

Which of the following is true about the effectiveness of therapy? Group of answer choicesUsually only one type of therapeutic technique is most effective for treatment There is not a major difference between treatment and placebos Therapy is often more effective than no treatment at all or placebos Therapy is not as effective as most people think it is

What is a placebo?Group of answer choicesA treatment that looks like, smells like, and tastes like the other treat- ments, but has no active ingredient.A treatment that looks like, smells like, and tastes like the other treat- ments, but has twice the active ingredient.A treatment that looks like, smells like, and tastes like the other treat- ments, but has less active ingredient.

The fact that certain types of people agree to participate in clinical trial may affect which of the following?Group of answer choicesplacebo effectvalidityrandomizationethics

To study the efficacy of a specific treatment for a particular psychiatric disorder, researchers will often employ a double-blind, placebo-controlled experiment. A double-blind study means that neither the participants nor the researchers know which participants are receiving the placebo, and which participants are receiving the treatment. These studies are designed to compare the results of the introduced treatment with that of a placebo on two groups of randomly selected patients.In the field of psychiatric drug development – also known as psychopharmacological drug development – placebo studies pose a significant problem in that they often result in negative findings. These are trials in which researchers have failed to demonstrate the superiority of the treatment over the placebo condition, and therefore pose a range of issues surrounding the validity of clinical drug development trials. The larger the placebo response, the more difficult it is to prove that an experimental treatment is effective.Describe what is meant by the term ‘placebo problem’ and explain how this can be problematic for psychopharmacological drug developers.